The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Application of rAAV in gene therapy of liver diseases
Author(s): 
Pages: 2392-2394
Year: Issue:  12
Journal: Biomagnetism

Keyword:  gene therapyLiverrecombinant adeno-associated virus;
Abstract: Gene therapy is a kind of new bio-medical treatment developed with modern molecular biology techniques in the last ten years. Recombinant adeno-associated virus is a potential vector, so it becomes a research hotspot in recent years. Hepatitis, cirrhosis and liver cancer are harmful to human healthy in China as well as all over the world. According to this, the researchers do a lot of work about recombinat adeno-associated virus (rAAV) gene therapy for liver disease. This paper reviewed the study about the application and the limitations of rAAV in gene therapy of liver diseases.
Related Articles
loading...